Dimethyl Sulphate Price Trend Analysis
- kunil kumar
- Jul 25, 2025
- 2 min read

What is Dimethyl Sulphate?
Dimethyl Sulphate (DMS) is a colorless, oily liquid widely used as a methylating agent in organic chemistry. It plays a key role in manufacturing dyes, pharmaceuticals, perfumes, agrochemicals, and quaternary ammonium compounds. Despite its utility, it is considered hazardous, making handling and transport subject to strict regulatory norms.
Global Dimethyl Sulphate Price Trend Overview
In 2024 and into 2025, the Dimethyl Sulphate price trend has been shaped by global supply chain dynamics and changes in demand patterns across industrial sectors. Asia, particularly China and India, remains a significant producer and exporter, while Europe and North America are major consumers.
Dimethyl Sulphate Price Trend – Quarterly Insights
Q3 2024: Prices rose moderately due to increasing raw material costs, specifically methanol and sulfuric acid. Environmental checks on chemical plants in China also led to limited supply, pushing prices higher.
Q4 2024: The market witnessed a correction as production levels normalized. Demand from agrochemical producers remained steady, contributing to price stability.
Q1 2025: Global prices climbed slightly due to fuel price hikes and increased freight costs. Buyers stockpiled material in anticipation of regulatory tightening.
Q2 2025: Prices began to soften due to lower methanol prices and easing of supply chain constraints. However, stringent safety regulations and export restrictions in some regions added cost pressure.
Key Factors Influencing Dimethyl Sulphate Prices
Raw Material Costs: Variations in methanol and sulfuric acid prices significantly influence the cost of DMS.
Regulatory Environment: Being a toxic and controlled chemical, compliance costs impact pricing.
Global Supply Chain: Logistics, energy prices, and geopolitical tensions can cause price shifts.
End-Use Demand: Pharmaceutical, agrochemical, and industrial chemical sectors affect market movement.
Regional Price Outlook
Asia-Pacific: Competitive pricing due to large-scale domestic production in China and India.
Europe: Prices are slightly higher due to import dependency and strict regulatory norms.
North America: Moderate pricing, with balanced supply and consistent demand from the pharmaceutical sector.



Comments